XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
$ in Thousands
Common stock
Preferred stock
Nonvested restricted stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained Earnings
Total
Balance at Dec. 31, 2021 $ 79 $ (1,435) $ 114,226 $ (740) $ 165,771 $ 277,901
Balance (in Shares) at Dec. 31, 2021 7,925,819          
Net income   7,970 7,970
Proceeds from exercise of stock options   579 579
Proceeds from exercise of stock options (in Shares) 18,125          
Issuance of restricted stock $ 1 (2,235) 2,234
Issuance of restricted stock (in Shares) 36,575          
Adoption of ASU 2016-13 (2,765) (2,765)
Compensation expense related to restricted stock, net of tax 245 245
Compensation expense related to stock options, net of tax 247 247
Other comprehensive income (Loss) (5,653) (5,653)
Balance at Mar. 31, 2022 $ 80 (3,425) 117,286 (6,393) 170,976 278,524
Balance (in Shares) at Mar. 31, 2022 7,980,519          
Balance at Dec. 31, 2022 $ 80 (3,306) 119,027 (13,410) 192,121 294,512
Balance (in Shares) at Dec. 31, 2022 8,011,045          
Net income 2,703 2,703
Proceeds from exercise of stock options   17 17
Proceeds from exercise of stock options (in Shares) 1,000          
Issuance of restricted stock (1,521) 1,521
Issuance of restricted stock (in Shares) 35,930          
Compensation expense related to restricted stock, net of tax 365 365
Compensation expense related to stock options, net of tax 118 118
Other comprehensive income (Loss) 1,635 1,635
Balance at Mar. 31, 2023 $ 80 $ (4,462) $ 120,683 $ (11,775) $ 194,824 $ 299,350
Balance (in Shares) at Mar. 31, 2023 8,047,975